1 June 2026 - Biotechnology company Anixa Biosciences Inc (NASDAQ: ANIX) reported on Monday that it has received a Notice of Allowance from the Canadian Intellectual Property Office for a patent covering key aspects of its ovarian cancer vaccine tech...
1 June 2026 - Clinical development partner hVIVO plc (AIM: HVO) announced on Monday that it has signed a consultancy agreement with Decoy Therapeutics to support the development of its respiratory antiviral portfolio, positioning the programmes for p...
1 June 2026 - Biopharmaceutical company AstraZeneca plc (STO:AZN) (LON:AZN) (NYSE:AZN) on Monday reported positive results from the EMERALD-3 Phase III trial evaluating IMFINZI (durvalumab) in combination with IMJUDO (tremelimumab-actl), lenvatinib a...
1 June 2026 - Clinical-stage biotechnology companies Rallybio Corporation (Nasdaq:RLYB) and Avenzo Therapeutics Inc announced on Monday that they have entered into a definitive merger agreement under which Rallybio will acquire Avenzo, with the combi...